ZINACEF

This brand name is authorized in Brazil, Cyprus, Estonia, Finland, Hong Kong, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, United Kingdom, South Africa

Active ingredients

The drug ZINACEF contains one active pharmaceutical ingredient (API):

1 Cefuroxime UNII R8A7M9MY61 - CEFUROXIME SODIUM

Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. Read about Cefuroxime

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZINACEF Powder for injection / infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510609001158311
Country: EE	Ravimiamet	Identifier(s): 1007031, 1007064
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 041013, 058966, 116046
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 39394, 45305, 47403
Country: HK	Department of Health Drug Office	Identifier(s): 07013, 07014, 07015
Country: IE	Health Products Regulatory Authority	Identifier(s): 55735, 82384
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3410
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015682, 1015683, 1017924
Country: MT	Medicines Authority	Identifier(s): MA685/04301, MA685/04302
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2782, 2783
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100074314, 100074320
Country: ZA	Health Products Regulatory Authority	Identifier(s): L/20.1.1/0096, L/20.1.1/0097